ALK+ Anaplastic Large Cell Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08870Brentuximab vedotin1 / 2Recruiting1
DB00619Imatinib1 / 2Recruiting1